• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Nanoscale ‘slingshot’ shoots drug to infection site

May 8, 2017 By Sarah Faulkner

DNA-based molecular slingshotResearchers from the University of Rome Tor Vergata and the University of Montreal have reported the design and synthesis of a nanoscale molecular slingshot made of DNA that could potentially shoot and target drugs to specific regions of the human body.

The slingshot is made of a synthetic DNA strand that can be loaded with drugs and act as the rubber band of a slingshot. The 2 ends of the “rubber band” have anchors that stick to a target antibody. When the anchors are triggered by the target antibody, the rubber band stretches and the loaded drug is released.

“One impressive feature about this molecular slingshot is that it can only be triggered by the specific antibody recognizing the anchoring tags of the DNA ‘rubber band’,” Francesco Ricci, associate professor of chemistry at the University of Rome Tor Vergata, said in prepared remarks. “By simply changing these tags, one can thus program the slingshot to release a drug in response to a variety of specific antibodies. Since different antibodies are markers of different diseases, this could become a very specific weapon in the clinician’s hands.”

“Another great property of our slingshot is its high versatility,” Alexis Vallée-Bélisle, assistant professor in the department of chemistry at the University of Montreal, added. “For example, until now we have demonstrated the working principle of the slingshot using 3 different trigger antibodies, including an HIV antibody, and employing nucleic acids as model drugs. But thanks to the high programmability of DNA chemistry, one can now design the DNA slingshot to ‘shoot’ a wide range of threrapeutic molecules.”

“Designing this molecular slingshot was a great challenge,” principal author Simona Ranallo said. “It required a long series of experiments to find the optimal design, which keeps the drug loaded in ‘rubber band’ in the absence of the antibody, without affecting too much its shooting efficiency once the antibody triggers the slingshot.”

The team plans to identify a specific disease and drug to test its slingshot in cells and then in mice.

“We envision that similar molecular slingshots may be used in the near future to deliver drugs to specific locations in the body. This would drastically improve the efficiency of drugs as well as decrease their toxic secondary effects,” Ricci said.

Filed Under: Featured, Pharmaceuticals, Preclinical Trials

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS